Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2065311000168116 | fentanyl 200 microgram / 100 mL + ropivacaine hydrochloride 200 mg / 100 mL injection, 5 x 100 mL bags (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2065321000168111 | ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, 5 x 100 mL bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, 5 x 100 mL bags | Is a | ropivacaine hydrochloride 200 mg/100 mL injection, 5 x 100 mL bags | true | Inferred relationship | Some | ||
| ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, 5 x 100 mL bags | has MPUU | ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, bag | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naropin 0.2% with Fentanyl 200 microgram/100 mL injection, 5 x 100 mL bags | Is a | True | ropivacaine hydrochloride 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, 5 x 100 mL bags | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
Medicinal product pack reference set
FHIR